Comments
Drug firm Lupin on Wednesday said it has launched generic antidepressant Fluoxetine tablets in the American market.
The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement.
The product is the generic version of Alvogen Group Holdings 3 LLC’s Fluoxetine tablets in the same strength, it added.
As per IQVIA MAT February 2019 data, Fluoxetine tablets 60mg had annual sales of around USD 41 million in the US, Lupin said.
The tablets are indicated for treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa and panic disorder with or without agoraphobia, it added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.